AI and regenerative medicine: AI-enabled manufacturing of stem-cell based therapies
9 March 2022 at 15:00 CET, Geneva | 09:00-10:30 EST, New York
The use of AI has the potential to transform many sectors in medicine. This AI for Good talk highlights AI applications in the manufacturing of stem cell-based therapies for regenerative medicines. Stem cell-derived regenerative medicines are poised to cure some of the toughest diseases within this decade, including Parkinson’s, diabetes, and heart disease. Patient-specific cells provide the safest, most effective cures for these indications. However, current autologous processes are not scalable due to extensive manual handling, high variability, and expensive facility overhead.